Generation of murine CTL by a hepatitis B virus-specific peptide and evaluation of the adjuvant effect of heat shock protein glycoprotein 96 and its terminal fragments

Journal of Immunology

Volumn 174, Issue 1, 2005, Pages 195-204

  Li, Hongtao ^a,b   Zhou, Minghai ^a,b   Han, Jinle ^a   Zhu, Xiaodong ^a,b   Dong, Tao ^c   Gao, George F ^a,c   Tien, Po ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 96; SERYLTYROSYLVALYLASPARAGINYLTHREONYLASPARAGINYLMETHIONYLGLYCYLLEUCINE; TETRAMER; TYROSYLVALYLASPARAGINYLTHREONYLASPARAGINYLMETHIONYLGLYCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; ESCHERICHIA COLI; FEMALE; HEPATITIS B VIRUS; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION;

EID: 10844266556     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.1.195     Document Type: Article

References (49)

1. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29.
2. Guidotti, L. G. 2003. Pathogenesis of viral hepatitis. J. Biol. Regul. Homeost. Agents 17:115.
3. Berwin, B., M. F. Rosser, K. G. Brinker, and C. V. Nicchitta. 2002. Transfer of GRP94(Gp96)-associated peptides onto endosomal MHC class I molecules. Traffic 3:358.
4. Berwin, B., and C. V. Nicchitta. 2001. To find the road traveled to tumor immunity: the trafficking itineraries of molecular chaperones in antigen-presenting cells. Traffic 2:690.
5. Binder, R. J., N. E. Blachere, and P. K. Srivastava. 2001. Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules. J. Biol. Chem. 276:17163.
6. Nicchitta, C. V. 2000. Role of chaperones in antigen processing. Immunol. Invest. 29:101.
7. Nicchitta, C. V. 2003. Re-evaluating the role of heat-shock protein-peptide interactions in rumour immunity. Nat. Rev. Immunol. 3:427.
8. Srivastava, P. K., H. Udono, N. E. Blachere, and Z. Li. 1994. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39:93.
9. Wassenberg, J. J., C. Dezfulian, and C. V. Nicchitta. 1999. Receptor mediated and fluid phase pathways for internalization of the ER Hsp90 chaperone GRP94 in murine macrophages. J. Cell Sci. 112:2167.
10. Meng, S. D., T. Gao, G. F. Gao, and P. Tien. 2001. HBV-specific peptide associated with heat-shock protein gp96. Lancet 357:528.
11. Meng, S. D., J. Song, Z. Rao, P. Tien, and G. F. Gao. 2002. Three-step purification of gp96 from human liver tumor tissues suitable for isolation of gp96-bound peptides. J. Immunol. Methods 264:29.
12. + cytotoxic T lymphocytes. J. Clin. Invest. 97:577.
13. Kuhrober, A., J. Wild, H. P. Pudollek, F. V. Chisari, and J. Reimann. 1997. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes. Int. Immunol. 9:1203.
14. Graner, M. W., Y. Zeng, H. Feng, and E. Katsanis. 2003. Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunol. Immunother 52:226.
15. Janetzki, S., D. Palla, V. Rosenhauer, H. Lochs, J. J. Lewis, and P. K. Srivastava. 2000. Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int. J. Cancer 88:232.
16. Castelli, C., L. Rivoltini, F. Rini, F. Belli, A. Testori, M. Maio, V. Mazzaferro, J. Coppa, P. K. Srivastava, and G. Parmiani. 2004. Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunol. Immunother. 53:227.
17. Srivastava, P. 2002, Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20:395.
18. Suto, R., and P. K. Srivastava. 1995. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269:1585.
19. Baker-LePain, J. C., M. Sarzotti, T. A. Fields, C. Y. Li, and C. V. Nicchitta. 2002. GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression. J. Exp. Med. 196:1447.
20. Baker-LePain, J. C., R. C. Reed, and C. V. Nicchitta. 2003. ISO: a critical evaluation of the role of peptides in heat shock/chaperone protein-mediated tumor rejection. Curr. Opin. Immunol. 15:89.
21. Reed, R. C., B. Berwin, J. P. Baker, and C. V. Nicchitta. 2003. GRP94/gp96 elicits ERK activation in murine macrophages: a role for endotoxin contamination in NF-κB activation and nitric oxide production. J. Biol. Chem. 278:31853.
22. Linderoth, N. A., A. Popowicz, and S. Sastry. 2000. Identification of the peptide-binding site in the heat shock chaperone/tumor rejection antigen gp96 (Grp94). J. Biol. Chem. 275:5472.
23. Gidalevitr, T., C. Biswas, H. Ding, D. Schneidman-Duhovny, H. J. Wolfson, F. Stevens, S. Radford, and Y. Argon. 2004. Identification of the N-terminal peptide binding site of GRP94. J. Biol. Chem. 279:16543.
24. Ogg, G. S., X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, et al. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103.
25. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
26. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89:3429.
27. Yu, M., E. Wang, Y. Liu, D. Cao, N. Jin, C. W. Zhang, M. Bartlam, Z. Rao, P. Tien, and G. F. Gao. 2002. Six-helix bundle assembly and characterization of heptad repeat regions from the F protein of Newcastle disease virus. J. Gen. Virol. 83:623.
28. Deng, Y., J. W. Yewdell, L. C. Eisenlohr, and J. R. Bennink. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507.
29. Blachere, N. E., Z. Li, R. Y. Chandawarkar, R. Suto, N. S. Jaikaria, S. Basu, H. Udono, and P. K. Srivastava. 1997. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186:1315.
30. Ciupitu, A. M., M. Petersson, C. L. O'Donnell, K. Williams, S. Jindal, R. Kiessling, and R. M. Welsh. 1998. Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J. Exp. Med. 187:685.
31. Chandawarkar, R. Y., M. S. Wagh, and P. K. Srivastava. 1999. The dual nature of specific immunological activity of tumor-derived gp96 preparations. J. Exp. Med. 189:1437.
32. Messaoudi, I., J. A. Guevara Patino, R. Dyall, J. LeMaoult, and J. Nikolich-Zugich. 2002. Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science 298:1797.
33. Ishii, T., H. Udono, T. Yamano, H. Ohta, A. Uenaka, T. Ono, A. Hizuta, N. Tanaka, P. K. Srivastava, and E. Nakayama. 1999. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J. Immunol. 162:1303.
34. + cells in vivo. J. Immunol. 165:6029.
35. Li, Z., J. Dai, H. Zheng, B. Liu, and M. Caudill. 2002. An integrated view of the roles and mechanisms of heat shock protein gp96-peptide complex in eliciting immune response. Front. Biosci. 7:d731.
36. Nicchitta, C. V., and R. C. Reed. 2000. The immunological properties of endoplasmic reticulum chaperones: a conflict of interest? Essays Biochem. 36:15.
37. + T cells in vivo. Proc. Natl. Acad. Sci. USA 91:3077.
38. Singh-Jasuja, H., N. Hilf, H. U. Scherer, D. Arnold-Schild, H. G. Rammensee, R. E. Toes, and H, Schild. 2000. The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells. Cell Stress Chaperones 5:462.
39. Heike, M., A. Weinmann, K. Bethke, and P. R. Galle. 1999. Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines. Biochem. Pharmacol. 58:1381.
40. Manjili, M. H., X. Y. Wang, J. Park, J. G. Facciponte, E. A. Repasky, and J. R. Subjeck. 2002. Immunotherapy of cancer using heat shock proteins. Front. Biosci. 7:d43.
41. Mazzaferro, V., J. Coppa, M. G. Carrabba, L. Rivoltini, M. Schiavo, E. Regalia, L. Mariani, T. Camerini, A. Marchiano, S. Andreola, et al. 2003. Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. Clin. Cancer Res. 9:3235.
42. Fleischer, K., B. Schmidt, W. Kastenmuller, D. H. Busch, I. Drexler, G. Sutler, M. Heike, C. Peschel, and H. Bernhard. 2004. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro. J. Immunol. 172:162.
43. Reed, R. C., T. Zheng, and C. V. Nicchitta. 2002, GRP94-associated enzymatic activities: resolution by chromatographic fractionation. J. Biol. Chem. 277:25082.
44. Audibert, F. 2003. Adjuvants for vaccines, a quest. Int. Immunopharmacol. 3:1187.
45. Azuma, K., S. Shichijo, H. Takedatsu, N. Komatsu, H. Sawamizu, and K. Itoh. 2003. Heat shock cognate protein 70 encodes antigenic epitopes recognised by HLA-B4601-restricted cytotoxic T lymphocytes from cancer patients. Br. J. Cancer 89:1079.
46. Udono, H., T. Yamano, Y. Kawabata, M. Ueda, and K. Yui. 2001. Generation ofcytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70. Int. Immunol. 13:1233.
47. Udono, H., and P. K. Srivastava. 1994. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol. 152:5398.
48. + T cell independent. J. Exp. Med. 191:403.
49. Suzue, K., and R. A. Young. 1996. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. J. Immunol. 156:873.